Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,381 to 1,400 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emergence of B.1.524(G) SARS-CoV-2 in Malaysia during the third COVID-19 epidemic wave. | Sci Rep | 2021 | 34764315 | PubTator, text mining | PubMed |
| Allosteric inhibition of SARS-CoV-2 3CL protease by colloidal bismuth subcitrate. | Chem Sci | 2021 | 34760193 | PubTator, text mining | PubMed |
| Discovery of SARS-CoV-2 Mpro peptide inhibitors from modelling substrate and ligand binding. | Chem Sci | 2021 | 34760153 | PubTator, text mining | PubMed |
| Concordance of X-ray and AlphaFold2 Models of SARS-CoV-2 Main Protease with Residual Dipolar Couplings Measured in Solution. | J Am Chem Soc | 2021 | 34757725 | PubTator, text mining | PubMed |
| SARS-COV-2, infection, transmission, transcription, translation, proteins, and treatment: A review. | Int J Biol Macromol | 2021 | 34756970 | PubTator, text mining | PubMed |
| A natural product compound inhibits coronaviral replication in vitro by binding to the conserved Nsp9 SARS-CoV-2 protein. | J Biol Chem | 2021 | 34756886 | PubTator, text mining | PubMed |
| Evaluation of Placentation and the Role of the Aryl Hydrocarbon Receptor Pathway in a Rat Model of Dioxin Exposure. | Environ Health Perspect | 2021 | 34747641 | PubTator, text mining | PubMed |
| The Omic Insights on Unfolding Saga of COVID-19. | Front Immunol | 2021 | 34745097 | PubTator, text mining | PubMed |
| De novo design of novel protease inhibitor candidates in the treatment of SARS-CoV-2 using deep learning, docking, and molecular dynamic simulations. | Comput Biol Med | 2021 | 34739968 | PubTator, text mining | PubMed |
| Polymorphic landscape of SARS-CoV-2 genomes isolated from Indian population in 2020 demonstrates rapid evolution in ORF3a, ORF8, nucleocapsid phosphoprotein and spike glycoprotein. | Comput Biol Chem | 2021 | 34736125 | PubTator, text mining | PubMed |
| Characterization of the SARS-CoV-2 genomes in Egypt in first and second waves of infection. | Sci Rep | 2021 | 34732835 | PubTator, text mining | PubMed |
| Insights on the SARS-CoV-2 genome variability: the lesson learned in Brazil and its impacts on the future of pandemics. | Microb Genom | 2021 | 34730486 | PubTator, text mining | PubMed |
| Evaluation of immunochromatography test for detection of four enteropathogens in the feces of sheep and goats in Kuwait. | Open Vet J | 2021 | 34722215 | PubTator, text mining | PubMed |
| Induction of UPR Promotes Interferon Response to Inhibit PRRSV Replication via PKR and NF-κB Pathway. | Front Microbiol | 2021 | 34712218 | PubTator, text mining | PubMed |
| COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks. | Int J Biol Macromol | 2021 | 34710479 | PubTator, text mining | PubMed |
| SARS-CoV-2-host proteome interactions for antiviral drug discovery. | Mol Syst Biol | 2021 | 34709727 | PubTator, text mining | PubMed |
| Structural, Electronic, and Electrostatic Determinants for Inhibitor Binding to Subsites S1 and S2 in SARS-CoV-2 Main Protease. | J Med Chem | 2021 | 34705466 | PubTator, text mining | PubMed |
| Attenuating innate immunity and facilitating β-coronavirus infection by NSP1 of SARS-CoV-2 through specific redistributing hnRNP A2/B1 cellular localization. | Signal Transduct Target Ther | 2021 | 34702797 | PubTator, text mining | PubMed |
| An Update on Innate Immune Responses during SARS-CoV-2 Infection. | Viruses | 2021 | 34696490 | PubTator, text mining | PubMed |
| SARS-CoV-2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro. | Viruses | 2021 | 34696485 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=70